Is this the end for ranitidine? NDMA presence continues to confound

Clin Transl Sci. 2021 Jul;14(4):1197-1200. doi: 10.1111/cts.12995. Epub 2021 May 2.

Authors

Jennifer A Wagner^{1

2}, Jean C Dinh^{1

2}, Jennifer R Lightdale^{3

4}, Benjamin D Gold⁵, Jennifer M Colombo^{1

2}

Affiliations

¹ Children's Mercy Hospital, Kansas City, Missouri, USA.
² University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
³ UMass Memorial Children's Medical Center, Worcester, Massachusetts, USA.
⁴ University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁵ GI Care for Kids, Children's Center for Digestive Healthcare, LLC, Atlanta, Georgia, USA.

No abstract available

MeSH terms

Dimethylnitrosamine / analysis*
Drug Contamination / legislation & jurisprudence*
Humans
Ranitidine / adverse effects*
Ranitidine / chemistry
Safety-Based Drug Withdrawals / legislation & jurisprudence*
United States
United States Food and Drug Administration / legislation & jurisprudence

Substances

Ranitidine
Dimethylnitrosamine